位置:首页 > 蛋白库 > HSLU_ECOLI
HSLU_ECOLI
ID   HSLU_ECOLI              Reviewed;         443 AA.
AC   P0A6H5; P32168; Q2M8M7;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 1.
DT   03-AUG-2022, entry version 144.
DE   RecName: Full=ATP-dependent protease ATPase subunit HslU;
DE   AltName: Full=Heat shock protein HslU;
DE   AltName: Full=Unfoldase HslU;
GN   Name=hslU; Synonyms=htpI; OrderedLocusNames=b3931, JW3902;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8244018; DOI=10.1016/0378-1119(93)90167-2;
RA   Chuang S.E., Burland V., Plunkett G. III, Daniels D.L., Blattner F.R.;
RT   "Sequence analysis of four new heat-shock genes constituting the
RT   hslTS/ibpAB and hslVU operons in Escherichia coli.";
RL   Gene 134:1-6(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8346018; DOI=10.1093/nar/21.15.3391;
RA   Plunkett G. III, Burland V., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome. III. DNA sequence of the region
RT   from 87.2 to 89.2 minutes.";
RL   Nucleic Acids Res. 21:3391-3398(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   MUTAGENESIS OF LYS-63.
RX   PubMed=8977096; DOI=10.1016/s0014-5793(96)01223-9;
RA   Shin D.H., Yoo S.J., Shim Y.K., Seol J.H., Kang M.S., Chung C.H.;
RT   "Mutational analysis of the ATP-binding site in HslU, the ATPase component
RT   of HslVU protease in Escherichia coli.";
RL   FEBS Lett. 398:151-154(1996).
RN   [6]
RP   FUNCTION, SUBSTRATE SPECIFICITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8662828; DOI=10.1074/jbc.271.24.14035;
RA   Yoo S.J., Seol J.H., Shin D.H., Rohrwild M., Kang M.-S., Tanaka K.,
RA   Goldberg A.L., Chung C.H.;
RT   "Purification and characterization of the heat shock proteins HslV and HslU
RT   that form a new ATP-dependent protease in Escherichia coli.";
RL   J. Biol. Chem. 271:14035-14040(1996).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=8650174; DOI=10.1073/pnas.93.12.5808;
RA   Rohrwild M., Coux O., Huang H.-C., Moerschell R.P., Yoo S.J., Seol J.H.,
RA   Chung C.H., Goldberg A.L.;
RT   "HslV-HslU: A novel ATP-dependent protease complex in Escherichia coli
RT   related to the eukaryotic proteasome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5808-5813(1996).
RN   [8]
RP   EFFECTS OF ATP BINDING ON COMPLEX FORMATION.
RX   PubMed=9299555; DOI=10.1006/bbrc.1997.7341;
RA   Yoo S.J., Seol J.H., Seong I.S., Kang M.-S., Chung C.H.;
RT   "ATP binding, but not its hydrolysis, is required for assembly and
RT   proteolytic activity of the HslVU protease in Escherichia coli.";
RL   Biochem. Biophys. Res. Commun. 238:581-585(1997).
RN   [9]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R., Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=9288941; DOI=10.1111/j.1432-1033.1997.01143.x;
RA   Seol J.H., Yoo S.J., Shin D.H., Shim Y.K., Kang M.-S., Goldberg A.L.,
RA   Chung C.H.;
RT   "The heat-shock protein HslVU from Escherichia coli is a protein-activated
RT   ATPase as well as an ATP-dependent proteinase.";
RL   Eur. J. Biochem. 247:1143-1150(1997).
RN   [11]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=9393683; DOI=10.1128/jb.179.23.7219-7225.1997;
RA   Kanemori M., Nishihara K., Yanagi H., Yura T.;
RT   "Synergistic roles of HslVU and other ATP-dependent proteases in
RT   controlling in vivo turnover of sigma32 and abnormal proteins in
RT   Escherichia coli.";
RL   J. Bacteriol. 179:7219-7225(1997).
RN   [12]
RP   MUTAGENESIS OF CYS-262 AND CYS-288.
RX   PubMed=9722513; DOI=10.1074/jbc.273.36.22929;
RA   Yoo S.J., Kim H.H., Shin D.H., Lee C.S., Seong I.S., Seol J.H.,
RA   Shimbara N., Tanaka K., Chung C.H.;
RT   "Effects of the cys mutations on structure and function of the ATP-
RT   dependent HslVU protease in Escherichia coli. The Cys287 to Val mutation in
RT   HslU uncouples the ATP-dependent proteolysis by HslvU from ATP
RT   hydrolysis.";
RL   J. Biol. Chem. 273:22929-22935(1998).
RN   [13]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10452560; DOI=10.1016/s0014-5793(99)00935-7;
RA   Seong I.S., Oh J.Y., Yoo S.J., Seol J.H., Chung C.H.;
RT   "ATP-dependent degradation of SulA, a cell division inhibitor, by the HslVU
RT   protease in Escherichia coli.";
RL   FEBS Lett. 456:211-214(1999).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, AND CHARACTERIZATION.
RX   PubMed=10419524; DOI=10.1074/jbc.274.31.22002;
RA   Kanemori M., Yanagi H., Yura T.;
RT   "Marked instability of the sigma(32) heat shock transcription factor at
RT   high temperature. Implications for heat shock regulation.";
RL   J. Biol. Chem. 274:22002-22007(1999).
RN   [15]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15696175; DOI=10.1038/nsmb898;
RA   Burton R.E., Baker T.A., Sauer R.T.;
RT   "Nucleotide-dependent substrate recognition by the AAA+ HslUV protease.";
RL   Nat. Struct. Mol. Biol. 12:245-251(2005).
RN   [16]
RP   REACTION MECHANISM.
RX   PubMed=19801685; DOI=10.1074/jbc.m109.045807;
RA   Lee J.W., Park E., Jeong M.S., Jeon Y.J., Eom S.H., Seol J.H., Chung C.H.;
RT   "HslVU ATP-dependent protease utilizes maximally six among twelve threonine
RT   active sites during proteolysis.";
RL   J. Biol. Chem. 284:33475-33484(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.81 ANGSTROMS) OF COMPLEXES WITH ATP AND HSLV.
RX   PubMed=10693812; DOI=10.1038/35001629;
RA   Bochtler M., Hartmann C., Song H.K., Bourenkov G.P., Bartunik H.D.,
RA   Huber R.;
RT   "The structures of HslU and the ATP-dependent protease HslU-HslV.";
RL   Nature 403:800-805(2000).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2-176 OF APOENZYME AND IN
RP   COMPLEXES WITH HSLV AND ATP, AND MUTAGENESIS OF LYS-80; GLU-88; TYR-91;
RP   VAL-92; GLY-93; GLU-95; GLU-266; GLU-286; ILE-312; GLU-321; ARG-325;
RP   GLU-385 AND ARG-393.
RX   PubMed=11114186; DOI=10.1073/pnas.250491797;
RA   Song H.K., Hartmann C., Ramachandran R., Bochtler M., Behrendt R.,
RA   Moroder L., Huber R.;
RT   "Mutational studies on HslU and its docking mode with HslV.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14103-14108(2000).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2-443 IN COMPLEX WITH ADP.
RX   PubMed=11709174; DOI=10.1016/s0969-2126(01)00670-0;
RA   Wang J., Song J.J., Seong I.S., Franklin M.C., Kamtekar S., Eom S.H.,
RA   Chung C.H.;
RT   "Nucleotide-dependent conformational changes in a protease-associated
RT   ATPase HslU.";
RL   Structure 9:1107-1116(2001).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (4.16 ANGSTROMS) IN COMPLEX WITH B.SUBTILIS HSLV AND
RP   ADP.
RX   PubMed=15983416; DOI=10.1107/s0907444905009546;
RA   Wang J., Rho S.H., Park H.H., Eom S.H.;
RT   "Correction of X-ray intensities from an HslV-HslU co-crystal containing
RT   lattice-translocation defects.";
RL   Acta Crystallogr. D 61:932-941(2005).
CC   -!- FUNCTION: ATPase subunit of a proteasome-like degradation complex; this
CC       subunit has chaperone activity. The binding of ATP and its subsequent
CC       hydrolysis by HslU are essential for unfolding of protein substrates
CC       subsequently hydrolyzed by HslV. HslU recognizes the N-terminal part of
CC       its protein substrates and unfolds these before they are guided to HslV
CC       for hydrolysis. {ECO:0000269|PubMed:10419524,
CC       ECO:0000269|PubMed:10452560, ECO:0000269|PubMed:15696175,
CC       ECO:0000269|PubMed:8650174, ECO:0000269|PubMed:8662828,
CC       ECO:0000269|PubMed:9288941, ECO:0000269|PubMed:9393683}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.31 mM for ATP (in the absence of HslV)
CC         {ECO:0000269|PubMed:15696175, ECO:0000269|PubMed:8662828};
CC         KM=0.28 mM for ATP (in the presence of HslV)
CC         {ECO:0000269|PubMed:15696175, ECO:0000269|PubMed:8662828};
CC         KM=5.2 uM for Arc-MYL-st11 (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:15696175, ECO:0000269|PubMed:8662828};
CC         Vmax=57 pmol/min/mg enzyme (in the absence of HslV)
CC         {ECO:0000269|PubMed:15696175, ECO:0000269|PubMed:8662828};
CC         Vmax=213 pmol/min/mg enzyme (in the presence of HslV)
CC         {ECO:0000269|PubMed:15696175, ECO:0000269|PubMed:8662828};
CC         Note=Arc is a repressor protein, Arc-MYL-st11 is a hyperstable
CC         variant of Arc.;
CC       Temperature dependence:
CC         Optimum temperature is 55 degrees Celsius.
CC         {ECO:0000269|PubMed:15696175, ECO:0000269|PubMed:8662828};
CC   -!- SUBUNIT: A double ring-shaped homohexamer of HslV is capped on each
CC       side by a ring-shaped HslU homohexamer. The assembly of the HslU/HslV
CC       complex is dependent on binding of ATP. {ECO:0000269|PubMed:11709174,
CC       ECO:0000269|PubMed:15983416}.
CC   -!- INTERACTION:
CC       P0A6H5; P0A6H5: hslU; NbExp=5; IntAct=EBI-369317, EBI-369317;
CC       P0A6H5; P0A7B8: hslV; NbExp=16; IntAct=EBI-369317, EBI-552265;
CC       P0A6H5; P0AFZ5: sulA; NbExp=5; IntAct=EBI-369317, EBI-2012039;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: By heat shock. {ECO:0000269|PubMed:8244018}.
CC   -!- SIMILARITY: Belongs to the ClpX chaperone family. HslU subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L19201; AAB03063.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76913.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77379.1; -; Genomic_DNA.
DR   PIR; JT0761; JT0761.
DR   RefSeq; NP_418366.1; NC_000913.3.
DR   RefSeq; WP_001293341.1; NZ_STEB01000017.1.
DR   PDB; 1DO0; X-ray; 3.00 A; A/B/C/D/E/F=2-443.
DR   PDB; 1DO2; X-ray; 4.00 A; A/B/C/D=2-443.
DR   PDB; 1E94; X-ray; 2.80 A; E/F=2-443.
DR   PDB; 1G4A; X-ray; 3.00 A; E/F=1-443.
DR   PDB; 1G4B; X-ray; 7.00 A; E/F/K/L=1-443.
DR   PDB; 1HQY; X-ray; 2.80 A; E/F=2-443.
DR   PDB; 1HT1; X-ray; 2.80 A; E/F/G/I=2-443.
DR   PDB; 1HT2; X-ray; 2.80 A; E/F/G/H=2-443.
DR   PDB; 1YYF; X-ray; 4.16 A; A/B=1-443.
DR   PDB; 5JI3; X-ray; 3.00 A; E/F=1-443.
DR   PDB; 5TXV; X-ray; 7.09 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=2-443.
DR   PDB; 6PXI; X-ray; 3.45 A; E/F=2-443.
DR   PDB; 6PXK; X-ray; 3.65 A; A/B/C/D/E/F/G/H/I/J/K/L=2-443.
DR   PDB; 6PXL; X-ray; 3.74 A; A/B/C/D/E/F/G/H/I/J/K/L=2-443.
DR   PDBsum; 1DO0; -.
DR   PDBsum; 1DO2; -.
DR   PDBsum; 1E94; -.
DR   PDBsum; 1G4A; -.
DR   PDBsum; 1G4B; -.
DR   PDBsum; 1HQY; -.
DR   PDBsum; 1HT1; -.
DR   PDBsum; 1HT2; -.
DR   PDBsum; 1YYF; -.
DR   PDBsum; 5JI3; -.
DR   PDBsum; 5TXV; -.
DR   PDBsum; 6PXI; -.
DR   PDBsum; 6PXK; -.
DR   PDBsum; 6PXL; -.
DR   AlphaFoldDB; P0A6H5; -.
DR   SMR; P0A6H5; -.
DR   BioGRID; 4261787; 251.
DR   ComplexPortal; CPX-2104; HslUV protease complex.
DR   DIP; DIP-31855N; -.
DR   IntAct; P0A6H5; 47.
DR   STRING; 511145.b3931; -.
DR   MEROPS; X20.005; -.
DR   SWISS-2DPAGE; P0A6H5; -.
DR   jPOST; P0A6H5; -.
DR   PaxDb; P0A6H5; -.
DR   PRIDE; P0A6H5; -.
DR   EnsemblBacteria; AAC76913; AAC76913; b3931.
DR   EnsemblBacteria; BAE77379; BAE77379; BAE77379.
DR   GeneID; 58459844; -.
DR   GeneID; 948430; -.
DR   KEGG; ecj:JW3902; -.
DR   KEGG; eco:b3931; -.
DR   PATRIC; fig|1411691.4.peg.2774; -.
DR   EchoBASE; EB1827; -.
DR   eggNOG; COG1220; Bacteria.
DR   HOGENOM; CLU_033123_0_0_6; -.
DR   InParanoid; P0A6H5; -.
DR   OMA; KYGMIKT; -.
DR   PhylomeDB; P0A6H5; -.
DR   BioCyc; EcoCyc:EG11881-MON; -.
DR   BioCyc; MetaCyc:EG11881-MON; -.
DR   BRENDA; 3.4.25.2; 2026.
DR   EvolutionaryTrace; P0A6H5; -.
DR   PRO; PR:P0A6H5; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0009376; C:HslUV protease complex; IDA:CAFA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:CAFA.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:CAFA.
DR   GO; GO:0008233; F:peptidase activity; IEA:InterPro.
DR   GO; GO:0036402; F:proteasome-activating activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0034605; P:cellular response to heat; IC:ComplexPortal.
DR   GO; GO:0030164; P:protein denaturation; IDA:ComplexPortal.
DR   GO; GO:0043335; P:protein unfolding; IMP:EcoCyc.
DR   GO; GO:0006508; P:proteolysis; IDA:CAFA.
DR   GO; GO:0051603; P:proteolysis involved in protein catabolic process; IBA:GO_Central.
DR   GO; GO:0009408; P:response to heat; IEP:EcoliWiki.
DR   DisProt; DP00100; -.
DR   Gene3D; 3.40.50.300; -; 1.
DR   HAMAP; MF_00249; HslU; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR019489; Clp_ATPase_C.
DR   InterPro; IPR004491; HslU.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR48102:SF3; PTHR48102:SF3; 1.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF07724; AAA_2; 1.
DR   Pfam; PF10431; ClpB_D2-small; 1.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM01086; ClpB_D2-small; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00390; hslU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Chaperone; Cytoplasm; Nucleotide-binding;
KW   Reference proteome; Stress response.
FT   CHAIN           1..443
FT                   /note="ATP-dependent protease ATPase subunit HslU"
FT                   /id="PRO_0000160500"
FT   BINDING         18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         60..65
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         256
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         321
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         393
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MUTAGEN         63
FT                   /note="K->T: Can neither bind nor hydrolyze ATP. Do not
FT                   form multimers, but stays as monomer."
FT                   /evidence="ECO:0000269|PubMed:8977096"
FT   MUTAGEN         80
FT                   /note="K->T: Some effect on protease activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         88
FT                   /note="E->Q: Severely reduced protease activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         91
FT                   /note="Y->G: Partial loss of protease activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         92
FT                   /note="V->G: Partial loss of protease activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         93
FT                   /note="G->A: Almost no protease or ATP hydrolysis
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         95
FT                   /note="E->W: Partial loss of protease activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         262
FT                   /note="C->V: No effect on ATP hydrolysis. Can support HslV-
FT                   mediated proteolysis at wild-type levels."
FT                   /evidence="ECO:0000269|PubMed:9722513"
FT   MUTAGEN         266
FT                   /note="E->Q: No effect."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         286
FT                   /note="E->Q: Reduced protease activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         288
FT                   /note="C->V: No ATP hydrolysis activity. Binds ATP with
FT                   lower affinity than wild-type. Can support HslV-mediated
FT                   proteolysis to some extent."
FT                   /evidence="ECO:0000269|PubMed:9722513"
FT   MUTAGEN         312
FT                   /note="I->W: No effect."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         321
FT                   /note="E->Q: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         325
FT                   /note="R->E: Complete loss of activity. Forms wild-type
FT                   complexes with HslV and is able to bind ATP."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         385
FT                   /note="E->K: No effect."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         393
FT                   /note="R->A: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11114186"
FT   MUTAGEN         436
FT                   /note="E->K: Partial loss of protease activity; when
FT                   associated with K-437."
FT   MUTAGEN         437
FT                   /note="D->K: Partial loss of protease activity; when
FT                   associated with K-436."
FT   HELIX           6..14
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           21..38
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           42..47
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          53..56
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           63..71
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   TURN            72..75
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          78..82
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           83..90
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           98..113
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   TURN            114..117
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           118..121
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           127..132
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   TURN            133..135
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   TURN            150..154
FT                   /evidence="ECO:0007829|PDB:1HQY"
FT   HELIX           155..161
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:1DO0"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:6PXI"
FT   HELIX           193..205
FT                   /evidence="ECO:0007829|PDB:6PXI"
FT   STRAND          214..216
FT                   /evidence="ECO:0007829|PDB:1DO0"
FT   HELIX           224..232
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           237..240
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           242..250
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          252..256
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           258..261
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           269..286
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          289..292
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          295..298
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           299..301
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          303..308
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          311..313
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           315..317
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           320..324
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          328..331
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           337..345
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           351..361
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          365..368
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           370..386
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           393..409
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           410..413
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   STRAND          417..420
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           422..434
FT                   /evidence="ECO:0007829|PDB:1E94"
FT   HELIX           436..442
FT                   /evidence="ECO:0007829|PDB:1E94"
SQ   SEQUENCE   443 AA;  49594 MW;  D2188639EA9AEF4C CRC64;
     MSEMTPREIV SELDKHIIGQ DNAKRSVAIA LRNRWRRMQL NEELRHEVTP KNILMIGPTG
     VGKTEIARRL AKLANAPFIK VEATKFTEVG YVGKEVDSII RDLTDAAVKM VRVQAIEKNR
     YRAEELAEER ILDVLIPPAK NNWGQTEQQQ EPSAARQAFR KKLREGQLDD KEIEIDLAAA
     PMGVEIMAPP GMEEMTSQLQ SMFQNLGGQK QKARKLKIKD AMKLLIEEEA AKLVNPEELK
     QDAIDAVEQH GIVFIDEIDK ICKRGESSGP DVSREGVQRD LLPLVEGCTV STKHGMVKTD
     HILFIASGAF QIAKPSDLIP ELQGRLPIRV ELQALTTSDF ERILTEPNAS ITVQYKALMA
     TEGVNIEFTD SGIKRIAEAA WQVNESTENI GARRLHTVLE RLMEEISYDA SDLSGQNITI
     DADYVSKHLD ALVADEDLSR FIL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024